Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 7
2001 6
2002 4
2003 1
2005 1
2006 3
2008 5
2009 2
2010 6
2011 7
2012 12
2013 14
2014 14
2015 12
2016 16
2017 18
2018 29
2019 17
2020 17
2021 31
2022 28
2023 32
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

259 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Focal emotional seizure with laughing"
Page 1
Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis.
Sultana B, Panzini MA, Veilleux Carpentier A, Comtois J, Rioux B, Gore G, Bauer PR, Kwon CS, Jetté N, Josephson CB, Keezer MR. Sultana B, et al. Neurology. 2021 Apr 27;96(17):805-817. doi: 10.1212/WNL.0000000000011839. Epub 2021 Mar 15. Neurology. 2021. PMID: 33722992
Meta-regression confirmed that the prevalence of DRE was higher in clinic-based populations and in focal epilepsy. Multiple predictors and correlates of DRE were identified. ...
Meta-regression confirmed that the prevalence of DRE was higher in clinic-based populations and in focal epilepsy. Multiple predictor …
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ, Sudell M, Cividini S, Marson AG, Tudur Smith C. Nevitt SJ, et al. Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4. Cochrane Database Syst Rev. 2022. PMID: 35363878 Free PMC article. Review.
OBJECTIVES: To compare the time to treatment failure, remission and first seizure of 12 AEDs (carbamazepine, phenytoin, sodium valproate, phenobarbitone, oxcarbazepine, lamotrigine, gabapentin, topiramate, eventrate, zonisamide, eslicarbazepine acetate, lacosamide) current …
OBJECTIVES: To compare the time to treatment failure, remission and first seizure of 12 AEDs (carbamazepine, phenytoin, sodium valpro …
Surgery for epilepsy.
West S, Nevitt SJ, Cotton J, Gandhi S, Weston J, Sudan A, Ramirez R, Newton R. West S, et al. Cochrane Database Syst Rev. 2019 Jun 25;6(6):CD010541. doi: 10.1002/14651858.CD010541.pub3. Cochrane Database Syst Rev. 2019. PMID: 31237346 Free PMC article.
BACKGROUND: This is an updated version of the original Cochrane review, published in 2015.Focal epilepsies are caused by a malfunction of nerve cells localised in one part of one cerebral hemisphere. In studies, estimates of the number of individuals with focal
BACKGROUND: This is an updated version of the original Cochrane review, published in 2015.Focal epilepsies are caused by a mal …
Lacosamide in status epilepticus: Systematic review of current evidence.
Strzelczyk A, Zöllner JP, Willems LM, Jost J, Paule E, Schubert-Bast S, Rosenow F, Bauer S. Strzelczyk A, et al. Epilepsia. 2017 Jun;58(6):933-950. doi: 10.1111/epi.13716. Epub 2017 Mar 11. Epilepsia. 2017. PMID: 28295226 Review.

Efficacy was comparable between use in nonconvulsive (57%; 82/145) and generalized-convulsive (61%; 30/49; p = 0.68) SE, whereas overall success rate was better in focal motor SE (92%; 34/39, p = 0.013; p < 0.001). The efficacy with later positioning of LCM decreased fr

Efficacy was comparable between use in nonconvulsive (57%; 82/145) and generalized-convulsive (61%; 30/49; p = 0.68) SE, whereas overall suc …
Prognosis of adults and children following a first unprovoked seizure.
Neligan A, Adan G, Nevitt SJ, Pullen A, Sander JW, Bonnett L, Marson AG. Neligan A, et al. Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2. Cochrane Database Syst Rev. 2023. PMID: 36688481 Free PMC article. Review.
SELECTION CRITERIA: We included studies, both retrospective and prospective, of all age groups (except those in the neonatal period (< 1 month of age)), of people with a single unprovoked seizure, followed up for a minimum of six months, with no upper limit of follow-up …
SELECTION CRITERIA: We included studies, both retrospective and prospective, of all age groups (except those in the neonatal period (< 1 …
Epilepsy (partial).
Maguire M, Marson AG, Ramaratnam S. Maguire M, et al. BMJ Clin Evid. 2011 May 6;2011:1214. BMJ Clin Evid. 2011. PMID: 21549021 Free PMC article. Review.
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of starting antiepileptic drug treatment following a single seizure? What are the effects of drug monotherapy in people with partial epi …
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of startin …
Epilepsy.
Marson AG, Maguire M, Ramaratnam S. Marson AG, et al. BMJ Clin Evid. 2009 Jan 28;2009:1201. BMJ Clin Evid. 2009. PMID: 19445769 Review.
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the benefits and risks of starting anti-epileptic drug treatment following a single seizure? What are the effects of monotherapy in newly diagnosed part
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the benefits and risks …
Gabapentin monotherapy for epilepsy: A review.
Ziganshina LE, Abakumova T, Hoyle CHV. Ziganshina LE, et al. Int J Risk Saf Med. 2023;34(3):243-286. doi: 10.3233/JRS-235001. Int J Risk Saf Med. 2023. PMID: 37393439 Review.
In this review we summarised the evidence from randomised controlled trials of gabapentin used as monotherapy for the treatment of focal epilepsy, both newly diagnosed and drug-resistant, with or without secondary generalisation. ...RESULTS: We found five randomised contro …
In this review we summarised the evidence from randomised controlled trials of gabapentin used as monotherapy for the treatment of focal
Cerebellar Degeneration in Epilepsy: A Systematic Review.
Ibdali M, Hadjivassiliou M, Grünewald RA, Shanmugarajah PD. Ibdali M, et al. Int J Environ Res Public Health. 2021 Jan 8;18(2):473. doi: 10.3390/ijerph18020473. Int J Environ Res Public Health. 2021. PMID: 33435567 Free PMC article. Review.
RESULTS: We identified three consistent predictors of cerebellar degeneration in the context of epilepsy in our review: temporal lobe epilepsy, poor seizure control, and phenytoin as the treatment modality. Whole brain and hippocampal atrophy were also identified in patien …
RESULTS: We identified three consistent predictors of cerebellar degeneration in the context of epilepsy in our review: temporal lobe epilep …
Neuro-stimulation in focal epilepsy: A systematic review and meta-analysis.
Skrehot HC, Englot DJ, Haneef Z. Skrehot HC, et al. Epilepsy Behav. 2023 May;142:109182. doi: 10.1016/j.yebeh.2023.109182. Epub 2023 Mar 25. Epilepsy Behav. 2023. PMID: 36972642 Review.
We performed a meta-analysis on VNS, RNS, and DBS outcomes to compare seizure reduction efficacy for focal epilepsy. METHODS: We systematically reviewed the literature for reported seizure outcomes following implantation with VNS, RNS, and DBS in focal
We performed a meta-analysis on VNS, RNS, and DBS outcomes to compare seizure reduction efficacy for focal epilepsy. METHODS: …
259 results